Scientists test 'One-Two Punch' cell therapy for patients who have run out of options

This early-stage study is testing a new two-part treatment for adults with aggressive blood cancers that have come back or not responded to other therapies. Doctors will first give patients a transplant of their own genetically edited stem cells, followed by an infusion of their own genetically edited immune cells (CAR-T cells). The main goal is to find a safe dose and see if this combined approach is feasible and shows early signs of fighting the cancer.